Tiger BioSciences is spotlighting a pivotal study originally published in the International Journal of Molecular Sciences.

After two decades in the making, scientists have cracked the code on a drug that can repair DNA, setting the scene for a new ...

Cedars-Sinai scientists have created a new experimental drug called TY1 that helps the body repair damaged DNA and restore ...

Cedars-Sinai researchers have created TY1, an experimental RNA-based drug that helps the body repair damaged DNA and restore injured tissue. The idea came from studying tiny molecular “messages” ...

"We are excited to see patients bene ting from this technological advance," said Christophe Bancel, Chief Executive Officer of TISSIUM."Dr. Franco's successful use of COAPTIUM (R) CONNECT underscores ...

TY1 enhances the action of TREX1, a gene that helps immune cells clear damaged DNA, helping to minimize scar tissue post heart attacks.

The global soft tissue repair market, valued at US$15.12 billion in 2024, stood at US$15.96 billion in 2025 and is projected to advance at a resilient CAGR of 5.1% from 2025 to 2030, culminating in a ...

A newly discovered cell that matures into two specialist cell types – an immune cell responsible for tissue repair and a cell that forms blood vessels – significantly boosts wound healing, according ...

Medical researchers have found a peptide which, when administered intravenously, homes in on the new blood vessels that are forming in damaged tissue. The peptide has been used as a delivery vehicle ...

According to iData's Global Market Report Suite for Soft Tissue Repair, the market was valued at $5 billion in 2021. This is expected to increase over the forecast period to reach $7.1 billion. This ...